Immuno Cure ^Company

Immuno Cure is a biotechnology company based in the Hong Kong Science Park. They specialize in the research and development of immunotherapies for cancer, inflammatory, and infectious diseases. Their patented PD-1-enhanced DNA vaccine and Anti-Δ42PD1 Antibody Immune Blockage Platforms are at the forefront of their innovative treatments. With two vaccines currently in first-in-human clinical trials, Immuno Cure is making significant strides in the field of immunotherapy.